
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, and
2 ICOS Corporation, Bothell, WA
Requests for reprints: Jac A. Nickoloff, Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM 87131. Phone: (505) 272-6960; Fax: (505) 272-6029. E-mail: jnickoloff{at}salud.unm.edu
DNA-dependent protein kinase (DNA-PK), composed of Ku70, Ku80, and the catalytic subunit (DNA-PKcs), is involved in double-strand break (DSB) repair by non-homologous end joining (NHEJ). DNA-PKcs defects confer ionizing radiation sensitivity and increase homologous recombination (HR). Increased HR is consistent with passive shunting of DSBs from NHEJ to HR. We therefore predicted that inhibiting the DNA-PKcs kinase would increase HR. A novel DNA-PKcs inhibitor (1-(2-hydroxy-4-morpholin-4-yl-phenyl)-ethanone; designated IC86621) increased ionizing radiation sensitivity but surprisingly decreased spontaneous and DSB-induced HR. Wortmannin also inhibits DNA-PKcs and reduces DSB-induced HR. IC86621 did not affect HR product outcome, indicating that it affects HR initiation. Thus, HR is increased in the absence of DNA-PKcs, but decreased when DNA-PKcs is catalytically inactive, suggesting interactive competition between HR and NHEJ. The effects of IC86621 and wortmannin were proportional to the level of DNA-PKcs, consistent with inhibited DNA-PKcs acting in a dominant negative manner. We propose that inhibition of DNA-PKcs blocks its autophosphorylation, prevents dissociation of DNA-PKcs from DNA ends, and thereby blocks both HR and NHEJ. By blocking the two major DSB repair pathways, DNA-PKcs inhibitors should radiosensitize at all cell-cycle stages and are therefore excellent candidates for augmenting cancer radiotherapy.
Key Words: DNA double-strand breaks DNA-dependent protein kinase spontaneous homologous recombination ionizing radiation
This article has been cited by other articles:
![]() |
W. Y. Mansour, S. Schumacher, R. Rosskopf, T. Rhein, F. Schmidt-Petersen, F. Gatzemeier, F. Haag, K. Borgmann, H. Willers, and J. Dahm-Daphi Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks Nucleic Acids Res., July 1, 2008; 36(12): 4088 - 4098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sallmyr, J. Fan, K. Datta, K.-T. Kim, D. Grosu, P. Shapiro, D. Small, and F. Rassool Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML Blood, March 15, 2008; 111(6): 3173 - 3182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amrein, M. Loignon, A.-C. Goulet, M. Dunn, B. Jean-Claude, R. Aloyz, and L. Panasci Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. White, D. Negorev, H. Peng, A. V. Ivanov, G. G. Maul, and F. J. Rauscher III KAP1, a Novel Substrate for PIKK Family Members, Colocalizes with Numerous Damage Response Factors at DNA Lesions Cancer Res., December 15, 2006; 66(24): 11594 - 11599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vasileva, R. M. Linden, and R. Jessberger Homologous recombination is required for AAV-mediated gene targeting Nucleic Acids Res., July 5, 2006; 34(11): 3345 - 3360. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Clejan, J. Boerckel, and S. Ahmed Developmental Modulation of Nonhomologous End Joining in Caenorhabditis elegans Genetics, July 1, 2006; 173(3): 1301 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, H. D. Thomas, M. A. Batey, I. G. Cowell, C. J. Richardson, R. J. Griffin, A. H. Calvert, D. R. Newell, G. C.M. Smith, and N. J. Curtin Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441. Cancer Res., May 15, 2006; 66(10): 5354 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Damaraju, D. Murray, J. Dufour, D. Carandang, S. Myrehaug, G. Fallone, C. Field, R. Greiner, J. Hanson, C. E. Cass, et al. Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer Clin. Cancer Res., April 15, 2006; 12(8): 2545 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sturgeon, Z. A. Knight, K. M. Shokat, and M. Roberge Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol. Cancer Ther., April 1, 2006; 5(4): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grabsch, M. Dattani, L. Barker, N. Maughan, K. Maude, O. Hansen, H. E. Gabbert, P. Quirke, and W. Mueller Expression of DNA Double-Strand Break Repair Proteins ATM and BRCA1 Predicts Survival in Colorectal Cancer Clin. Cancer Res., March 1, 2006; 12(5): 1494 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jovanovic and W. S. Dynan Terminal DNA structure and ATP influence binding parameters of the DNA-dependent protein kinase at an early step prior to DNA synapsis Nucleic Acids Res., February 18, 2006; 34(4): 1112 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Wang, W.-C. Chou, S.-Y. Shieh, and C.-Y. Shen Ataxia Telangiectasia Mutated and Checkpoint Kinase 2 Regulate BRCA1 to Promote the Fidelity of DNA End-Joining Cancer Res., February 1, 2006; 66(3): 1391 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, Y. Yu, S. Gupta, Y.-M. Cho, S. P. Lees-Miller, and K. Meek Autophosphorylation of DNA-Dependent Protein Kinase Regulates DNA End Processing and May Also Alter Double-Strand Break Repair Pathway Choice Mol. Cell. Biol., December 15, 2005; 25(24): 10842 - 10852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Di Primio, A. Galli, T. Cervelli, M. Zoppe, and G. Rainaldi Potentiation of gene targeting in human cells by expression of Saccharomyces cerevisiae Rad52 Nucleic Acids Res., August 16, 2005; 33(14): 4639 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Boeckman, K. S. Trego, and J. J. Turchi Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining Mol. Cancer Res., May 1, 2005; 3(5): 277 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Convery, E. K. Shin, Q. Ding, W. Wang, P. Douglas, L. S. Davis, J. A. Nickoloff, S. P. Lees-Miller, and K. Meek Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) PNAS, February 1, 2005; 102(5): 1345 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fan, T. S. Kumaravel, F. Jalali, P. Marrano, J. A. Squire, and R. G. Bristow Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells: Implications for Genetic Instability and Prostate Cancer Progression Cancer Res., December 1, 2004; 64(23): 8526 - 8533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Nowicki, R. Falinski, M. Koptyra, A. Slupianek, T. Stoklosa, E. Gloc, M. Nieborowska-Skorska, J. Blasiak, and T. Skorski BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks Blood, December 1, 2004; 104(12): 3746 - 3753. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferrara and E. B. Kmiec Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination Nucleic Acids Res., October 5, 2004; 32(17): 5239 - 5248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. R. Reddy, Q. Ding, S. P. Lees-Miller, K. Meek, and D. A. Ramsden Non-homologous End Joining Requires That the DNA-PK Complex Undergo an Autophosphorylation-dependent Rearrangement at DNA Ends J. Biol. Chem., September 17, 2004; 279(38): 39408 - 39413. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Block, Y. Yu, D. Merkle, J. L. Gifford, Q. Ding, K. Meek, and S. P. Lees-Miller Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends Nucleic Acids Res., August 16, 2004; 32(14): 4351 - 4357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bailey, M. A. Brenneman, and E. H. Goodwin Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells Nucleic Acids Res., July 16, 2004; 32(12): 3743 - 3751. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Geng, J. Tan, E. Himmelfarb, A. Schueneman, K. Niermann, A. Fu, K. Cuneo, E. A. Kesicki, J. Treiberg, J. S. Hayflick, et al. A Specific Antagonist of the p110{delta} Catalytic Component of Phosphatidylinositol 3'-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction Cancer Res., July 15, 2004; 64(14): 4893 - 4899. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Monnat Jr. and Y. Saintigny Werner Syndrome Protein--Unwinding Function to Explain Disease Sci. Aging Knowl. Environ., March 31, 2004; 2004(13): re3 - re3. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |